Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C

Journal of Physiology

Volumn 593, Issue 5, 2015, Pages 1127-1146

  Egom, Emmanuel E ^a   Vella, Kimberly ^a   Hua, Rui ^a   Jansen, Hailey J ^a   Moghtadaei, Motahareh ^a   Polina, Iuliia ^a   Bogachev, Oleg ^a   Hurnik, Rhea ^a   Mackasey, Martin ^a   Rafferty, Sara ^a   Ray, Gibanananda ^a   Rose, Robert A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; COLLAGEN; NATRIURETIC PEPTIDE RECEPTOR C; ATRIAL NATRIURETIC FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; EPICARDIUM MAPPING; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE POTENTIAL; HEART STIMULATION; HISTOPATHOLOGY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PATCH CLAMP TECHNIQUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SINUS ARRHYTHMIA; SINUS NODE CONDUCTION VELOCITY; WILD TYPE MOUSE; ACTION POTENTIAL; ANIMAL; ATRIAL FIBRILLATION; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SINUS NODE;

ACTION POTENTIALS; ANIMALS; ATRIAL FIBRILLATION; CELLS, CULTURED; COLLAGEN; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SINOATRIAL NODE;

EID: 84923571212     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.283135     Document Type: Article

References (68)

1. Anand-Srivastava MB (2005). Natriuretic peptide receptor-C signaling and regulation. Peptides 26, 1044-1059.
2. Anand-Srivastava MB & Trachte GJ (1993). Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45, 455-497.
3. Azer J, Hua R, Vella K & Rose RA (2012). Natriuretic peptides regulate heart rate and sinoatrial node function by activating multiple natriuretic peptide receptors. J Mol Cell Cardiol 53, 715-724.
4. Azer J, Hua R, Krishnaswamy PS & Rose RA (2014). Effects of natriuretic peptides on electrical conduction in the sinoatrial node and atrial myocardium of the heart. J Physiol 592, 1025-1045.
5. Becker JR, Chatterjee S, Robinson TY, Bennett JS, Panakova D, Galindo CL, Zhong L, Shin JT, Coy SM, Kelly AE, Roden DM, Lim CC & MacRae CA (2014). Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development. Development 141, 335-345.
6. Berul CI, Aronovitz MJ, Wang PJ & Mendelsohn ME (1996). In vivo cardiac electrophysiology studies in the mouse. Circulation 94, 2641-2648.
7. Burnett JC, Jr. & Korinek J ( 2008). The tumultuous journey of nesiritide: past, present, and future. Circ Heart Fail 1, 6-8.
8. Burstein B & Nattel S (2008). Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51, 802-809.
9. Calvieri C, Rubattu S & Volpe M (2012). Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. J Mol Med (Berl) 90, 5-13.
10. Camelliti P, Borg TK & Kohl P (2005). Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 65, 40-51.
11. Cataliotti A & Burnett JC, Jr (2005). Natriuretic peptides: novel therapeutic targets in heart failure. J Investig Med 53, 378-384.
12. Cheema AN, Ahmed MW, Kadish AH & Goldberger JJ (1995). Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol 26, 497-502.
13. Chinkers M & Wilson EM (1992). Ligand-independent oligomerization of natriuretic peptide receptors. Identification of heteromeric receptors and a dominant negative mutant. J Biol Chem 267, 18589-18597.
14. Dobrzynski H, Boyett MR & Anderson RH (2007). New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 115, 1921-1932.
15. Farman GP, Tachampa K, Mateja R, Cazorla O, Lacampagne A & de Tombe PP (2008). Blebbistatin: use as inhibitor of muscle contraction. Pflugers Arch 455, 995-1005.
16. Fedorov VV, Hucker WJ, Dobrzynski H, Rosenshtraukh LV & Efimov IR (2006). Postganglionic nerve stimulation induces temporal inhibition of excitability in rabbit sinoatrial node. Am J Physiol Heart Circ Physiol 291, H612-623.
17. Fedorov VV, Chang R, Glukhov AV, Kostecki G, Janks D, Schuessler RB & Efimov IR (2010). Complex interactions between the sinoatrial node and atrium during reentrant arrhythmias in the canine heart. Circulation 122, 782-789.
18. Fedorov VV, Glukhov AV & Chang R (2012). Conduction barriers and pathways of the sinoatrial pacemaker complex: their role in normal rhythm and atrial arrhythmias. Am J Physiol Heart Circ Physiol 302, H1773-H1783.
19. Feridooni T, Hotchkiss A, Remley-Carr S, Saga Y & Pasumarthi KB (2011). Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes. PLoS One 6, e22801.
20. Fukui A, Takahashi N, Nakada C, Masaki T, Kume O, Shinohara T, Teshima Y, Hara M & Saikawa T (2013). Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Circ Arrhythm Electrophysiol 6, 402-409.
21. Glukhov AV, Fedorov VV, Anderson ME, Mohler PJ & Efimov IR (2010). Functional anatomy of the murine sinus node: high-resolution optical mapping of ankyrin-B heterozygous mice. Am J Physiol Heart Circ Physiol 299, H482-H491.
22. Horio T, Tokudome T, Maki T, Yoshihara F, Suga S, Nishikimi T, Kojima M, Kawano Y & Kangawa K (2003). Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 144, 2279-2284.
23. Hua R, Adamczyk A, Robbins C, Ray G & Rose RA (2012). Distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium. PLoS One 7, e47652.
24. Huntley BK, Sandberg SM, Noser JA, Cataliotti A, Redfield MM, Matsuda Y & Burnett JC, Jr (2006). BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors. J Cell Physiol 209, 943-949.
25. Jalife J, Berenfeld O & Mansour M (2002). Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc Res 54, 204-216.
26. Jaubert J, Jaubert F, Martin N, Washburn LL, Lee BK, Eicher EM & Guenet JL (1999). Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc Natl Acad Sci USA 96, 10278-10283.
27. Kapoun AM, Liang F, O'Young G, Damm DL, Quon D, White RT, Munson K, Lam A, Schreiner GF & Protter AA (2004). B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94, 453-461.
28. Kassiri Z & Khokha R (2005). Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors. Thromb Haemost 93, 212-219.
29. Kawakami R, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Nakagawa Y, Nakanishi M, Tanimoto K, Usami S, Yasuno S, Kinoshita H, Chusho H, Tamura N, Ogawa Y & Nakao K (2004). Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction. Circulation 110, 3306-3312.
30. Krogh-Madsen T, Abbott GW & Christini DJ (2012). Effects of electrical and structural remodeling on atrial fibrillation maintenance: a simulation study. PLoS Comput Biol 8, e1002390.
31. Lee CY & Burnett JC, Jr (2007). Natriuretic peptides and therapeutic applications. Heart Fail Rev 12, 131-142.
32. Lee CY, Lieu H & Burnett JC, Jr (2009). Designer natriuretic peptides. J Investig Med 57, 18-21.
33. Levin ER, Gardner DG & Samson WK (1998). Natriuretic peptides. N Engl J Med 339, 321-328.
34. Li P, Wang D, Lucas J, Oparil S, Xing D, Cao X, Novak L, Renfrow MB & Chen YF (2008). Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102, 185-192.
35. Liu J, Dobrzynski H, Yanni J, Boyett MR & Lei M (2007). Organisation of the mouse sinoatrial node: structure and expression of HCN channels. Cardiovasc Res 73, 729-738.
36. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP & Waldman SA (2000). Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52, 375-414.
37. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA & Lewicki JA (1987). Physiological role of silent receptors of atrial natriuretic factor. Science 238, 675-678.
38. f) in isolated mouse sinoatrial cells. Cardiovasc Res 52, 51-64.
39. Mangoni ME & Nargeot J (2008). Genesis and regulation of the heart automaticity. Physiol Rev 88, 919-982.
40. Marionneau C, Couette B, Liu J, Li H, Mangoni ME, Nargeot J, Lei M, Escande D & Demolombe S (2005). Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 562, 223-234.
41. Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M & Smithies O (1999). The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 96, 7403-7408.
42. Morley GE, Vaidya D, Samie FH, Lo C, Delmar M & Jalife J (1999). Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 10, 1361-1375.
43. Narula OS, Samet P & Javier RP (1972). Significance of the sinus-node recovery time. Circulation 45, 140-158.
44. Nattel S ( 2002). New ideas about atrial fibrillation 50 years on. Nature 415, 219-226.
45. Nygren A, Lomax AE & Giles WR (2004). Heterogeneity of action potential durations in isolated mouse left and right atria recorded using voltage-sensitive dye mapping. Am J Physiol Heart Circ Physiol 287, H2634-H2643.
46. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalan R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Mendez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F & Califf RM (2011). Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365, 32-43.
47. i activator sequences that inhibit adenylyl cyclase activity. J Biol Chem 276, 22064-22070.
48. Parthasarathy A, Gopi V, Umadevi S, Simna A, Sheik MJ, Divya H & Vellaichamy E (2013). Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts. Mol Cell Biochem 378, 217-228.
49. Potter LR, Abbey-Hosch S & Dickey DM (2006). Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27, 47-72.
50. Rae J, Cooper K, Gates P & Watsky M (1991). Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37, 15-26.
51. Rohr S ( 2009). Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? Heart Rhythm 6, 848-856.
52. Rose RA ( 2010). CD-NP, a chimeric natriuretic peptide for the treatment of heart failure. Curr Opin Investig Drugs 11, 349-356.
53. Rose RA & Giles WR (2008). Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol 586, 353-366.
54. 2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect. Am J Physiol Heart Circ Physiol 285, H2454-H2462.
55. Rose RA, Lomax AE, Kondo CS, Anand-Srivastava MB & Giles WR (2004). Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor. Am J Physiol Heart Circ Physiol 286, H1970-H1977.
56. Rose RA, Hatano N, Ohya S, Imaizumi Y & Giles WR (2007a). C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptor-mediated signalling. J Physiol 580, 255-274.
57. Rose RA, Kabir MG & Backx PH (2007b). Altered heart rate and sinoatrial node function in mice lacking the cAMP regulator phosphoinositide 3-kinase-gamma. Circ Res 101, 1274-1282.
58. 2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circ Arrhythm Electrophysiol 4, 733-742.
59. Soeki T, Kishimoto I, Okumura H, Tokudome T, Horio T, Mori K & Kangawa K (2005). C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol 45, 608-616.
60. Springer J, Azer J, Hua R, Robbins C, Adamczyk A, McBoyle S, Bissell MB & Rose RA (2012). The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors. J Mol Cell Cardiol 52, 1122-1134.
61. Stafford PJ, Turner I & Vincent R (1991). Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol 68, 751-755.
62. 2+ clock genes underlying sinoatrial node pacemaking. Exp Physiol 96, 1163-1178.
63. Tsuruda T, Boerrigter G, Huntley BK, Noser JA, Cataliotti A, Costello-Boerrigter LC, Chen HH & Burnett JC, Jr (2002). Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 91, 1127-1134.
64. Verheijck EE, van Kempen MJ, Veereschild M, Lurvink J, Jongsma HJ & Bouman LN (2001). Electrophysiological features of the mouse sinoatrial node in relation to connexin distribution. Cardiovasc Res 52, 40-50.
65. Wolf RM, Glynn P, Hashemi S, Zarei K, Mitchell CC, Anderson ME, Mohler PJ & Hund TJ (2013). Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis. Am J Physiol Heart Circ Physiol 304, H1253-H1266.
66. Yue L, Xie J & Nattel S (2011). Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 89, 744-753.
67. Zhou H & Murthy KS (2003). Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C). Am J Physiol Cell Physiol 284, C1255-C1261.
68. Zlochiver S, Munoz V, Vikstrom KL, Taffet SM, Berenfeld O & Jalife J (2008). Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys J 95, 4469-4480.